KYOTO HEALTH CO., LTD. ANNOUNCED ON 1 JANUARY 2024 THAT UNDER THE INITIAL PUBLIC OFFERING SHARE AWARD SCHEME, THE GROUP'S EMPLOYEES (EXCLUDING DIRECTORS AND SENIOR MANAGEMENT) WERE AWARDED 1,210,742 SHARES OF BONUS SHARES, REPRESENTING APPROXIMATELY 0.04% OF THE TOTAL NUMBER OF SHARES ISSUED. The market price of the award shares is HK$39.10 per share and the grant price is zero. The allotment period for the bonus shares varies, with a minimum of 0 to 2 years from the date of issue and a maximum of 1 to 4 years. Some bonus shares have an allotment period of less than 12 months for reasons including compensatory share awards and administrative management reasons. Awarded bonus shares are not accompanied by performance targets but are subject to a chargeback mechanism. In...Show More

KYOTO HEALTH CO., LTD. ANNOUNCED ON 1 JANUARY 2024 THAT UNDER THE INITIAL PUBLIC OFFERING SHARE AWARD SCHEME, THE GROUP'S EMPLOYEES (EXCLUDING DIRECTORS AND SENIOR MANAGEMENT) WERE AWARDED 1,210,742 SHARES OF BONUS SHARES, REPRESENTING APPROXIMATELY 0.04% OF THE TOTAL NUMBER OF SHARES ISSUED. The market price of the award shares is HK$39.10 per share and the grant price is zero. The allotment period for the bonus shares varies, with a minimum of 0 to 2 years from the date of issue and a maximum of 1 to 4 years. Some bonus shares have an allotment period of less than 12 months for reasons including compensatory share awards and administrative management reasons. Awarded bonus shares are not accompanied by performance targets but are subject to a chargeback mechanism. In the event of a breach of the rules by the grantor, the unassigned or vested bonus shares will be forfeited or written off. The purpose of awarding is to encourage employees to align with the interests of the company and to contribute to long-term growth. The new shares will have the same rights as the issued shares and will not be raised through the issuance of new shares.